116 related articles for article (PubMed ID: 2165798)
1. Okadaic acid: a reversible inhibitor of neoplastic transformation of mouse fibroblasts.
Mordan LJ; Dean NM; Honkanen RE; Boynton AL
Cancer Commun; 1990; 2(7):237-41. PubMed ID: 2165798
[TBL] [Abstract][Full Text] [Related]
2. Okadaic acid inhibits PDGF-induced proliferation and decreases PDGF receptor number in C3H/10T1/2 mouse fibroblasts.
Dean NM; Mordan LJ; Tse K; Mooberry SL; Boynton AL
Carcinogenesis; 1991 Apr; 12(4):665-70. PubMed ID: 1849470
[TBL] [Abstract][Full Text] [Related]
3. v-Src-induced transformation is inhibited by okadaic acid.
Gupta RW; Joseph CK; Foster DA
Biochem Biophys Res Commun; 1993 Oct; 196(1):320-7. PubMed ID: 8216307
[TBL] [Abstract][Full Text] [Related]
4. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors.
DeFranco DB; Qi M; Borror KC; Garabedian MJ; Brautigan DL
Mol Endocrinol; 1991 Sep; 5(9):1215-28. PubMed ID: 1663212
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity.
Taffs RE; Redegeld FA; Sitkovsky MV
J Immunol; 1991 Jul; 147(2):722-8. PubMed ID: 1649222
[TBL] [Abstract][Full Text] [Related]
6. Okadaic acid and phorbol esters: comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro.
Katoh F; Fitzgerald DJ; Giroldi L; Fujiki H; Sugimura T; Yamasaki H
Jpn J Cancer Res; 1990; 81(6-7):590-7. PubMed ID: 2119362
[TBL] [Abstract][Full Text] [Related]
7. Flat reversion by okadaic acid of raf and ret-II transformants.
Sakai R; Ikeda I; Kitani H; Fujiki H; Takaku F; Rapp U; Sugimura T; Nagao M
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9946-50. PubMed ID: 2690080
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
Bertram JS
Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
[TBL] [Abstract][Full Text] [Related]
9. Okadaic acid regulation of the retinoblastoma gene product is correlated with the inhibition of growth factor-induced cell proliferation in mouse fibroblasts.
Kim TA; Velasquez BR; Wenner CE
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5460-3. PubMed ID: 8390667
[TBL] [Abstract][Full Text] [Related]
10. Role of protein phosphatases in malignant transformation.
Nagao M; Sakai R; Kitagawa Y; Ikeda I; Sasaki K; Shima H; Sugimura T
Princess Takamatsu Symp; 1989; 20():177-84. PubMed ID: 2562181
[TBL] [Abstract][Full Text] [Related]
11. Okadaic acid markedly potentiates the heat-induced hsp 70 promoter activity.
Chang NT; Huang LE; Liu AY
J Biol Chem; 1993 Jan; 268(2):1436-9. PubMed ID: 8380412
[TBL] [Abstract][Full Text] [Related]
12. Induction by growth factors from platelets of the focus-forming transformed phenotype in carcinogen-treated C3H/10T1/2 fibroblasts.
Mordan LJ
Carcinogenesis; 1988 Jul; 9(7):1129-34. PubMed ID: 3383332
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2.
Amaral MC; Casillas AM; Nel AE
Immunology; 1993 May; 79(1):24-31. PubMed ID: 8389730
[TBL] [Abstract][Full Text] [Related]
14. Protein serine/threonine phosphatases as binding proteins for okadaic acid.
Nagao M; Shima H; Nakayasu M; Sugimura T
Mutat Res; 1995 Dec; 333(1-2):173-9. PubMed ID: 8538625
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH
Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901
[TBL] [Abstract][Full Text] [Related]
16. Effects of okadaic acid on cell growth, anchorage-independent growth, and co-cultures of normal (KMS-6), immortalized (KMST-6), and neoplastically transformed (KMST-6T and KMST-6/RAS) human fibroblasts.
Jahan I; Iijima M; Kondo T; Namba M
J Cancer Res Clin Oncol; 1996; 122(4):249-53. PubMed ID: 8601579
[TBL] [Abstract][Full Text] [Related]
17. Okadaic acid, a phosphatase inhibitor, enhances the phorbol ester-induced interleukin-1 beta expression via an AP-1-mediated mechanism.
Hurme M; Matikainen S
Scand J Immunol; 1993 Dec; 38(6):570-4. PubMed ID: 8256116
[TBL] [Abstract][Full Text] [Related]
18. Ability of okadaic acid and other protein phosphatase inhibitors to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production in mouse epidermis in vivo.
Newell SW; Perchellet EM; Gao XM; Chen G; Perchellet JP
Cancer Lett; 1996 Jan; 98(2):241-51. PubMed ID: 8556715
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation, and cell proliferation by the phosphatase inhibitor okadaic acid.
Schönthal A; Feramisco JR
Oncogene; 1993 Feb; 8(2):433-41. PubMed ID: 8381221
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship within a series of okadaic acid derivatives.
Nishiwaki S; Fujiki H; Suganuma M; Furuya-Suguri H; Matsushima R; Iida Y; Ojika M; Yamada K; Uemura D; Yasumoto T
Carcinogenesis; 1990 Oct; 11(10):1837-41. PubMed ID: 2170047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
